Results from a Parkinson's UK funded study showed the app could help improve many aspects of mental health. The app is available now and free to download.
The English Football League (EFL) and Football Association of Wales (FAW) have launched new walking football programmes to help more people with Parkinson's to get active.
Two separate research studies have both shown promising early results for a treatment that aims to replace brain cells that are lost in Parkinson's.
We've awarded Pretzel Therapeutics £200,000 to investigate a new drug which could prevent cells from dying in Parkinson's.
In our latest round of grants we've awarded funding for new projects that aim to improve symptoms of Parkinson's without the need for extra medication.
The first participant has received either ambroxol or the placebo in the ASPro-PD trial. This marks the start of 330 people with Parkinson's taking a component of an already approved drug over 2 years to see if it is beneficial.
We're supporting Sport Parkinson's and Cure Parkinson's with the delivery of their annual Try-Athlon event to help more Parkinson's communities to give physical activities a try.
The National Institute for Health and Care Excellence (NICE) has published new guidelines asking health professionals to address gambling related harms when supporting people with Parkinson's.
Parkinson's UK and the UK Dementia Research Institute (UK DRI) join forces to establish a pioneering research centre.
A study predicting health trends worldwide suggests that incidence of Parkinson's is rising due to an ageing population.
Nearly £600,000 has been awarded to 2 outstanding scientists to develop their Parkinson's research careers.
A physical activity register of approved instructors has been created to help more people get active with Parkinson's in a safe and accessible way.
The full results show that exenatide had no benefits over the placebo and didn't slow the progression of Parkinson's.
The government has announced plans to reform elective (planned) health care in England to reduce waiting lists and give patients more choice, but more is needed for people with Parkinson's.
We're excited to reveal our refreshed brand, developed with the Parkinson's community.
A small study of a drug called propranolol looked effective in easing tremor both at rest and in stressful situations for people with Parkinson's.
We're disappointed that Lecigon, a new treatment for advanced Parkinson's, has been rejected by NHS Scotland. We're increasingly concerned about access to advanced treatments in Scotland.